Tanis: a link between type 2 diabetes and inflammation?

Here we describe a novel protein, which we have named Tanis, that is implicated in type 2 diabetes and inflammation. In Psammomys obesus, a unique polygenic animal model of type 2 diabetes and the metabolic syndrome, Tanis is expressed in the liver in inverse proportion to circulating glucose (P = 0.010) and insulin levels (P = 0.004) and in direct proportion with plasma triglyceride concentrations (P = 0.007). Hepatic Tanis gene expression was markedly increased (3.1-fold) after a 24-h fast in diabetic but not in nondiabetic P. obesus. In addition, glucose inhibited Tanis gene expression in cultured hepatocytes (P = 0.006) as well as in several other cell types (P = 0.001-0.011). Thus, Tanis seems to be regulated by glucose and is dysregulated in the diabetic state. Yeast-2 hybrid screening identified serum amyloid A (SAA), an acute-phase inflammatory response protein, as an interacting protein of Tanis, and this was confirmed by Biacore experiments. SAA and other acute-phase proteins have been the focus of recent attention as risk factors for cardiovascular disease, and we contend that Tanis and its interaction with SAA may provide a mechanistic link among type 2 diabetes, inflammation, and cardiovascular disease.

[1]  P. Zimmet,et al.  A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus , 1994, Diabetologia.

[2]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[3]  Timothy McCaffrey,et al.  A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation , 2001, Nature Medicine.

[4]  N. Shastri,et al.  Distinguishing Self from Nonself: Immunogenicity of the Murine H47 Locus Is Determined by a Single Amino Acid Substitution in an Unusual Peptide1 , 2001, The Journal of Immunology.

[5]  P. Zimmet,et al.  Beacon: a novel gene involved in the regulation of energy balance. , 2000 .

[6]  Janine McMillan,et al.  Beacon: A novel gene involved in the regulation of energy balance , 2000, Regulatory Peptides.

[7]  J. Peña,et al.  Enhanced Acute-Phase Response and Oxidative Stress in Older Adults with Type II Diabetes , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[8]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[9]  P. Zimmet,et al.  Characterization of Obesity Phenotypes in Psammomys Obesus (Israeli Sand Rats) , 2000, International journal of experimental diabetes research.

[10]  E. Ziv,et al.  Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes. , 1999, Metabolism: clinical and experimental.

[11]  T. Rönnemaa,et al.  Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes , 1999, Diabetologia.

[12]  N. Rifai,et al.  Inflammatory markers in men with angiographically documented coronary heart disease. , 1999, Clinical chemistry.

[13]  M. Groenen,et al.  Detection of quantitative trait loci for backfat thickness and intramuscular fat content in pigs (Sus scrofa). , 1999, Genetics.

[14]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[15]  C. Wanner,et al.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.

[16]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[17]  J. Rotter,et al.  Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. , 1997, Circulation.

[18]  P. Zimmet,et al.  Development of Obesity and Insulin Resistance in the Israeli Sand Rat (Psammomys obesus) Does Leptin Play a Role? , 1997, Annals of the New York Academy of Sciences.

[19]  D. Pomp.  Genetic Dissection of Obesity in Polygenic Animal Models , 1997, Behavior genetics.

[20]  E. Ziv,et al.  Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state , 1996, Diabetologia.

[21]  J. Cheverud,et al.  Quantitative trait loci for murine growth. , 1996, Genetics.

[22]  M. Fridkin,et al.  Effect of serum amyloid A, HDL-apolipoprotein, on endothelial cell proliferation. Implication of an enigmatic protein to atherosclerosis. , 1996, Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity.

[23]  P. Keightley,et al.  A genetic map of quantitative trait loci for body weight in the mouse. , 1996, Genetics.

[24]  P. Zimmet,et al.  Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus. , 1995, Acta diabetologica.

[25]  C. Semenkovich,et al.  Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetics of decay after glucose deprivation. , 1995, Journal of lipid research.

[26]  Y. Ikeda,et al.  Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus. , 1994, Clinical biochemistry.

[27]  B. Lunenfeld,et al.  Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Shafrir,et al.  PSAMMOMYS OBESUS OF THE JERUSALEM COLONY: A MODEL FOR NUTRITIONALLY INDUCED, NON-INSULIN-DEPENDENT DIABETES , 1993, Journal of basic and clinical physiology and pharmacology.

[29]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[30]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[31]  A. Consoli,et al.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. , 1990, The Journal of clinical investigation.

[32]  C. Ucla,et al.  Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[34]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[35]  E. Levy,et al.  Characterization of Stages in Development of Obesity-Diabetes Syndrome in Sand Rat (Psammomys obesus) , 1986, Diabetes.

[36]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[37]  L. Mandarino.  Insulin and glucagon binding to isolated hepatocytes of Egyptian sand rats (Psammomys obesus): evidence for an insulin receptor defect. , 1984, Comparative biochemistry and physiology. A, Comparative physiology.

[38]  P. Zimmet,et al.  Ethnic Variability in the Plasma Insulin Response to Oral Glucose in Polynesian and Micronesian Subjects , 1979, Diabetes.

[39]  P. Felig,et al.  The metabolic events of starvation. , 1976, The American journal of medicine.

[40]  G F Cahill,et al.  Starvation in man. , 1970, The New England journal of medicine.

[41]  D. Kipnis,et al.  Hormone-fuel interrelationships during fasting. , 1966, The Journal of clinical investigation.